Minor histocompatibility antigens as determinants for graft-versus-host disease after allogeneic haematopoietic stem cell transplantation

被引:11
|
作者
Turpeinen, H. [1 ]
Ojala, P. J. [1 ]
Ojala, K. [2 ]
Miettinen, M. [1 ]
Volin, L. [3 ]
Partanen, J. [1 ]
机构
[1] Finnish Red Cross Blood Serv, Helsinki 00310, Finland
[2] Univ Helsinki, FIMM Inst Mol Med Finland, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Dept Med, Div Haematol, Helsinki, Finland
关键词
RISK-ASSESSMENT; ACUTE GVHD; DISPARITY; RELEVANCE; MISMATCH; HA-1;
D O I
10.1111/iji.12051
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Minor histocompatibility antigens (minor H antigens) are genetically polymorphic peptides that have been shown to elicit immune response when mismatched between donor and recipient of haematopoietic stem cell transplantation (HSCT). Depending on the expression profiles, mismatches in these genes may either lead to harmful graft-versus-host (GvH) reaction or desired graft-versus-leukaemia (GvL) effect. We analysed retrospectively the effect of HLA-restricted matching 11 established autosomal minor H antigens on the risk of graft-versus-host disease and relapse in 311 HLA-matched sibling HSCT of a single centre. Increased incidence of chronic GvH disease was shown to be associated with mismatches in the HA-8 and ACC-1. The mRNA expression profiles in a large set of healthy and malignant tissue samples of minor H antigen genes demonstrated in silico that the expression profiles of HA-8 and ACC-1 were surprisingly different: HA-8 gene was expressed in practically all tissues, whereas ACC-1 gene had a restricted profile. The results demonstrated that mismatches in minor H antigens HA-8 and ACC-1 predisposed to chronic graft-versus-host disease (GvHD).
引用
收藏
页码:495 / 501
页数:7
相关论文
共 50 条
  • [31] The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation
    Nordlander, A
    Uzunel, M
    Mattsson, J
    Remberger, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (04) : 1133 - 1136
  • [32] Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation
    Kim, Seo Yeon
    Lee, Hyewon
    Han, Mi-Soon
    Shim, Hyoeun
    Eom, Hyeon-Seok
    Park, Boram
    Kong, Sun-Young
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (09): : 527 - 535
  • [33] A dynamic time-to-event model for prediction of acute graft-versus-host disease in patients after allogeneic hematopoietic stem cell transplantation
    Och, Katharina
    Turki, Amin T.
    Goetz, Katharina M.
    Selzer, Dominik
    Brossette, Christian
    Theobald, Stefan
    Braun, Yvonne
    Graf, Norbert
    Rauch, Jochen
    Rohm, Kerstin
    Weiler, Gabriele
    Kiefer, Stephan
    Schwarz, Ulf
    Eisenberg, Lisa
    Pfeifer, Nico
    Ihle, Matthias
    Grandjean, Andrea
    Fix, Sonja
    Riede, Claudia
    Rissland, Juergen
    Smola, Sigrun
    Beelen, Dietrich W.
    Kaddu-Mulindwa, Dominic
    Bittenbring, Joerg
    Lehr, Thorsten
    CANCER MEDICINE, 2024, 13 (01):
  • [34] A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Jo, Tomoyasu
    Arai, Yasuyuki
    Kanda, Junya
    Kondo, Tadakazu
    Ikegame, Kazuhiro
    Uchida, Naoyuki
    Doki, Noriko
    Fukuda, Takahiro
    Ozawa, Yukiyasu
    Tanaka, Masatsugu
    Ara, Takahide
    Kuriyama, Takuro
    Katayama, Yuta
    Kawakita, Toshiro
    Kanda, Yoshinobu
    Onizuka, Makoto
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Terakura, Seitaro
    COMMUNICATIONS MEDICINE, 2023, 3 (01):
  • [35] Impact of Underlying Disease and Total Body Irradiation on the Incidence of Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
    Puckrin, Robert
    Kinzel, Megan
    Stewart, Douglas
    Chaudhry, Ahsan
    Jamani, Kareem
    Storek, Jan
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (03): : 176e1 - 176e8
  • [36] Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation
    Shen, Meng-Zhu
    Liu, Xin-Xin
    Qiu, Zhi-Yuan
    Xu, Lan-Ping
    Zhang, Xiao-Hui
    Wang, Yu
    Yan, Chen-Hua
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Liu, Si-Ning
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Mo, Xiao-Dong
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [37] Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease
    Martin, Paul J.
    Levine, David M.
    Storer, Barry E.
    Warren, Edus H.
    Zheng, Xiuwen
    Nelson, Sarah C.
    Smith, Anajane G.
    Mortensen, Bo K.
    Hansen, John A.
    BLOOD, 2017, 129 (06) : 791 - 798
  • [38] Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
    Anna Cäcilia Ingham
    Katrine Kielsen
    Hanne Mordhorst
    Marianne Ifversen
    Frank M. Aarestrup
    Klaus Gottlob Müller
    Sünje Johanna Pamp
    Microbiome, 9
  • [39] Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
    Ingham, Anna Cacilia
    Kielsen, Katrine
    Mordhorst, Hanne
    Ifversen, Marianne
    Aarestrup, Frank M.
    Mueller, Klaus Gottlob
    Pamp, Sunje Johanna
    MICROBIOME, 2021, 9 (01)
  • [40] Lipocalin-2 levels in acute and chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
    Hermann, Alexander
    Winkler, Andreas
    Paschen, Christopher
    Kuzmina, Zoya
    Hladik, Anastasiya
    Icme, Suephan
    Robak, Oliver
    EXPERIMENTAL HEMATOLOGY, 2019, 74 : 25 - 32